Sanara MedTech Inc.

NasdaqCM:SMTI Stock Report

Market Cap: US$274.6m

Sanara MedTech Past Earnings Performance

Past criteria checks 0/6

Sanara MedTech's earnings have been declining at an average annual rate of -31%, while the Medical Equipment industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 42% per year.

Key information

-31.0%

Earnings growth rate

-14.9%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate42.0%
Return on equity-10.0%
Net Margin-6.6%
Next Earnings Update13 May 2024

Recent past performance updates

Recent updates

Is Sanara MedTech (NASDAQ:SMTI) Using Too Much Debt?

Nov 15
Is Sanara MedTech (NASDAQ:SMTI) Using Too Much Debt?

Investors Still Waiting For A Pull Back In Sanara MedTech Inc. (NASDAQ:SMTI)

May 22
Investors Still Waiting For A Pull Back In Sanara MedTech Inc. (NASDAQ:SMTI)

Sanara MedTech Inc. (NASDAQ:SMTI) Analysts Are Pretty Bullish On The Stock After Recent Results

Mar 22
Sanara MedTech Inc. (NASDAQ:SMTI) Analysts Are Pretty Bullish On The Stock After Recent Results

Sanara MedTech: Differentiated Offering With Niche Wound Care Exposure

Sep 06

Sanara MedTech reports Q2 results

Aug 15

Here's Why We're Not At All Concerned With Sanara MedTech's (NASDAQ:SMTI) Cash Burn Situation

Dec 31
Here's Why We're Not At All Concerned With Sanara MedTech's (NASDAQ:SMTI) Cash Burn Situation

Sanara MedTech: Technology For Faster Healing Wounds

Dec 08

Sanara Medtech inks exclusive partnership with Pixalere Healthcare

Jun 04

Companies Like Sanara MedTech (NASDAQ:SMTI) Can Afford To Invest In Growth

May 18
Companies Like Sanara MedTech (NASDAQ:SMTI) Can Afford To Invest In Growth

Neil Cataldi From Blueprint Discusses Sanara MedTech

May 03

The Sanara MedTech (NASDAQ:SMTI) Share Price Has Soared 510%, Delighting Many Shareholders

Feb 19
The Sanara MedTech (NASDAQ:SMTI) Share Price Has Soared 510%, Delighting Many Shareholders

Is Sanara MedTech Inc. (NASDAQ:SMTI) Popular Amongst Insiders?

Dec 28
Is Sanara MedTech Inc. (NASDAQ:SMTI) Popular Amongst Insiders?

Revenue & Expenses Breakdown
Beta

How Sanara MedTech makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqCM:SMTI Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2365-4574
30 Sep 2363-8554
30 Jun 2360-9534
31 Mar 2354-6504
31 Dec 2246-8463
30 Sep 2238-7412
30 Jun 2230-8361
31 Mar 2227-10320
31 Dec 2124-8280
30 Sep 2122-5240
30 Jun 2120-4220
31 Mar 2117-4190
31 Dec 2016-4190
30 Sep 2014-6180
30 Jun 2013-5160
31 Mar 2013-4160
31 Dec 1912-3130
30 Sep 1911-1110
30 Jun 1910090
31 Mar 199080
31 Dec 189080
30 Sep 188070
30 Jun 187070
31 Mar 187060
31 Dec 176050
30 Sep 176050
30 Jun 176050
31 Mar 176-150
31 Dec 166-140
30 Sep 164-140
30 Jun 164-240
31 Mar 163-130
31 Dec 153-230
30 Sep 153-130
30 Jun 153-240
31 Mar 153-240
31 Dec 143-340
30 Sep 142-450
30 Jun 142-550
31 Mar 142-440
31 Dec 132-440
30 Sep 132-310
30 Jun 132-320

Quality Earnings: SMTI is currently unprofitable.

Growing Profit Margin: SMTI is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: SMTI is unprofitable, and losses have increased over the past 5 years at a rate of 31% per year.

Accelerating Growth: Unable to compare SMTI's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: SMTI is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (6.3%).


Return on Equity

High ROE: SMTI has a negative Return on Equity (-9.96%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.